# Orthocare Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orthocare-co

- Industry: Software
- Headquarters: Seoul, South Korea
- Website: www.orthocare.co.kr/
- Total disclosed funding: $0.4M
- Latest round: Seed (Jun 27, 2025)
- Investors on record: 1

## About

Based in South Korea, Orthocare Co., Ltd. specializes in orthopedic rehabilitation, offering innovative solutions through its technology-driven platform that enhances patient recovery processes and outcomes.Orthocare Co., Ltd. is dedicated to developing orthopedic rehabilitation solutions, having been founded in 2024 in Seoul, South Korea. The company has successfully completed its first deal, securing KRW 500 million in a Seed funding round on June 27, 2025, led by FuturePlay, which has contributed to a total amount raised of KRW 500 million. No significant pivots or changes in business strategy have been reported.Orthocare is at the forefront of innovating orthopedic rehabilitation through its core product offerings, primarily centered around the Anapa app. This application enables users to perform rehabilitation exercises independently and accurately assess their movements through precise motion analysis and coaching. By leveraging big data analytics, Orthocare provides personalized rehabilitation programs tailored to individual patient needs, facilitating effective recovery from musculoskeletal disorders. The app aims to address the challenges faced post-surgery, such as the lack of proper rehabilitation tools and feedback mechanisms, which often result in prolonged recovery times and increased costs for patients. Orthocare's solutions are designed for a wide clientele, including orthopedic patients across various geographical markets, with a particular focus on technology adoption in regions such as South Korea and beyond.Orthocare generates revenue through a combination of direct-to-consumer sales and potential partnerships with healthcare providers. Clients can access the Anapa app, which may operate on a subscription model, providing ongoing support and access to personalized rehabilitation programs. Revenue streams are bolstered by partnerships with healthcare institutions and clinics that integrate Orthocare's technology into their rehabilitation processes. The structure of transactions typically involves healthcare providers purchasing licenses for the app, which can then be offered to their patients, thus ensuring a steady flow of income. The company’s emphasis on advanced rehabilitation solutions positions it competitively in the healthcare technology market, underscoring its commitment to improving patient outcomes while fostering financial growth.In June 2025, Orthocare Co., Ltd. raised KRW 500 million in Seed funding from new investor FuturePlay. The company will utilize this funding to develop digital therapeutics and enhance its offerings to users. Plans for future growth include the launch of new products aimed at improving orthopedic rehabilitation solutions and potential expansion into additional geographic markets beyond South Korea.

## Funding rounds

- Seed, Jun 27, 2025, $0.4M — FuturePlay

## Investors

- FuturePlay (https://capitalatlas.ai/funds/futureplay) — Seed